Plerixafor ‘on demand’: results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF
- 9 December 2013
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 49 (3) , 453-455
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixaforLeukemia & Lymphoma, 2013
- Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or LenalidomideTransplantation and Cellular Therapy, 2012
- Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or LymphomaTransplantation and Cellular Therapy, 2012
- Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With LymphomaJournal of Clinical Oncology, 2011
- Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experienceEuropean Journal of Haematology, 2011
- Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use dataBone Marrow Transplantation, 2010
- Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2009
- AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use dataBone Marrow Transplantation, 2007
- Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSFLeukemia, 2005
- Enumeration of CD34+ cells in cord blood: A variation on a single‐platform flow cytometric method based on the ISHAGE gating strategyCytometry, 2001